CLOV Earnings Clover Health Investments, Corp. /De
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–18 of 18
| Q1 2026 | 2026-03-31 | 0.05 | 2026-05-08 | 10-Q |
| Q1 2026 | 2025-03-31 | 0.00 | 2026-05-08 | 10-Q |
| FY 2023 | 2023-12-31 | -0.44 | 2024-03-14 | 10-K |
| Q3 2023 | 2023-09-30 | -0.30 | 2023-11-06 | 10-Q |
| Q2 2023 | 2023-06-30 | -0.21 | 2023-08-08 | 10-Q |
| Q1 2023 | 2023-03-31 | -0.15 | 2023-05-09 | 10-Q |
| FY 2023 | 2022-12-31 | -0.71 | 2024-03-14 | 10-K |
| Q3 2023 | 2022-09-30 | -0.54 | 2023-11-06 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.38 | 2023-08-08 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.16 | 2023-05-09 | 10-Q |
| FY 2023 | 2021-12-31 | -1.42 | 2024-03-14 | 10-K |
| Q3 2022 | 2021-09-30 | -0.98 | 2022-11-07 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.93 | 2022-08-08 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.13 | 2022-05-09 | 10-Q |
| FY 2022 | 2020-12-31 | -1.54 | 2023-03-01 | 10-K |
| Q3 2021 | 2020-09-30 | -0.11 | 2021-11-09 | 10-Q |
| Q2 2021 | 2020-06-30 | -0.26 | 2021-08-11 | 10-Q |
| FY 2021 | 2019-12-31 | -4.14 | 2022-02-28 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.